Clinical Trial Search

Primary: Insulin Sensitivity — 273; 817 nmol/kg FFM/min /(µU/mL Insulin)

Primary: Linear Relationship Between HOMA-IR and Cognitive Function (R-squared) — 0.205; 0.299; 0.738; 0.0264 R-squared — p=0.162

Primary: Percent Change in Free Testosterone (T) — -6.9; -35.8; 12.1 percent change

Primary: Striatal DRD2 Receptor Binding — 28; 33; 32; 33 ratio — p=<0.05

Primary: Change From Baseline in Insulin Sensitivity as Measured by Glucose Infusion Rate (GIR) — 17.95; 1.68 micromols/kg of FFM/minute — p=<0.001

Primary: Insulin Signaling With Lipid Infusion — 0.4334; 0.7276; 0.5264; 0.3534 ratio

Primary: Insulin Sensitivity — 0.0105; -0.0076; 0.0041 micro mol/min/Kg/mU/L/year

Primary: Renal Clearance of D-chiroinositol (DCI) at 12 Days — 4.75; 5.16 ml/min

Primary: Glucose Disposal Rate (Rd)- the Rate of Glucose Infusion to Maintain Euglycemia During Steady State Insulin Infusion in mg/Min — 709; 429; 842; 497 mg/min — p=0.136

Primary: Insulin Sensitivity — 8 m value — p=<0.05

Primary: Adipose Tissue Capillary Sprout Formation — 143.5; 122.1 number of capillary sprouts

Primary: Change in Insulin Resistance — 37.4; 36.3 μmol/kg/min (Step 2 GIR corrected)

Primary: Triglycerides Levels at Week 12 — 210.6; 235.8 mg/dL — p=0.131

Primary: Whole-body Glucose Utilization (Rd) — 8.5; 11.0; 12.1 mg/kg FFM/min

Primary: Insulin Sensitivity — 3.06; 3.33 units on a scale

Primary: Insulin Sensitivity After 5-7 Days of Exercise — 3; 2.5 index score — p=<0.05

Primary: Change in Muscle Strength — 0.37; -0.2 Ratio

Primary: Peripheral Insulin Sensitivity (RD) Measured by the Change in Glucose Rates of Disappearance With Resveratrol or Placebo at Baseline and at 4 Weeks. — 6.573; 7.272…

Primary: Hamilton Depression Rating Scale (HDRS-21) — 19.9; 13.0 units on a scale

Primary: Glucose — 7.1; 6.4 mmol/L

Primary: Exploring Insulin Sensitivity After 10-20 Years of Follow-up — 7 mg/kg/min — p=<0.05

Primary: Adiponectin — -0.71; -7.52 µg/mL

Primary: Insulin Sensitivity Difference Between Patients With Atopic Dermatitis and Controls — 9.8; 9.2 mg glucose/kg body mass/minute

Primary: Fasting Insulin — 8.1; 8.0; 6.3 uIU/mL — p=0.181

Primary: Change in Systemic Glucose Disposal- Glucose Infusion Rates — 1; 6 percent change from baseline — p=<0.05

Primary: Change in Fasting Plasma Glucose Concentration — 4.7; 0.0 mmol/l

Primary: Body Composition — 39; 39; 37; 39 percentage

Primary: Recurrent Fatal or Non-fatal Stroke, or Fatal or Non-fatal Myocardial Infarction — 175; 228 participants — p=.0067

Primary: Insulin Sensitivity — 1.48; 1.73; 1.89; 2.93 mg*kg^-1*min^-1

Primary: Change From Baseline in Homeostatic Model Assessment Fasting Beta Cell Function (HOMA % B) at 4 Years — 50.2; 48.3 Percentage of Beta Cell Function — p=0.24